The protective and therapeutic function of small heat shock proteins in neurological diseases

Frontiers in Immunology

Volumn 3, Issue MAY, 2012, Pages

  Brownell, Sara E ^a   Becker, Rachel A ^a   Steinman, Lawrence ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

HSPB1; HSPB5; Neuroinflammation; Neurological diseases; SHSPs; Small heat shock proteins

Indexed keywords

EID: 84874157611     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00074     Document Type: Review

References (108)

1. Ackerley, S., James, P. A., Kalli, A., French, S., Davies, K. E., and Talbot, K. (2006). A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum. Mol. Genet. 15, 347-354.
2. Akbar, M. T., Lundberg, A. M., Liu, K., Vidyadaran, S., Wells, K. E., Dolatshad,H.,Wynn,S.,Wells,D. J.,Latchman, D. S., and de Belleroche, J. (2003). The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J. Biol. Chem. 278, 19956-19965.
3. Andley, U. P. (2007). Crystallins in the eye: function and pathology. Prog. Retin. Eye Res. 26, 78-98.
4. Aquino, D. A., Capello, E., Weisstein, J., Sanders, V., Lopez, C., Tourtellotte, W. W., Brosnan, C. F., Raine, C. S., and Norton, W. T. (1997). Multiple sclerosis: altered expression of 70-and 27-kDa heat shock proteins in lesions and myelin. J. Neuropathol. Exp. Neurol. 56, 664-672.
5. Arac, A., Brownell, S. E., Rothbard, J. B., Chen, C., Ko, R. M., Pereira, M. P., Albers, G. W., Steinman, L., and Steinberg, G. K. (2011). Systematic augmentation of alpha B crystallin, a novel immunomodulatory target, provides therapeutic benefit twelve hours post-stroke onset. Proc. Natl. Acad. Sci. U.S.A. 108, 13287-13292.
6. Armstrong, C. L., Krueger-Naug, A. M., Currie, R. W., and Hawkes, R. (2001). Constitutive expression of heat shock protein HSP25 in the central nervous system of the developing and adult mouse. J. Comp. Neurol. 434, 262-274.
7. Arrigo, A. P., Simon, S., Gibert, B., Kretz-Remy, C., Nivon, M., Czekalla, A., Guillet, D., Moulin, M., Diaz-Latoud, C., and Vicart, P. (2007). Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 581, 3665-3674.
8. Badin, R. A., Lythgoe, M. F., van der Weerd, L., Thomas, D. L., Gadian, D. G., and Latchman, D. S. (2006). Neuroprotective effects of virally delivered HSPs in experimental stroke. J. Cereb. Blood Flow Metab. 26, 371-381.
9. Bagnéris, C., Bateman, O. A., Naylor, C. E., Cronin, N., Boelens, W. C., Keep, N. H., and Slingsby, C. (2009). Crystal structures of alpha-crystallin domain dimers of alphaB-crystallin and Hsp20. J. Mol. Biol. 392, 1242-1252.
10. Bajramovic, J. J., Lassmann, H., and van Noort, J. M. (1997). Expression of alphaB-crystallin in glia cells during lesional development in multiple sclerosis. J. Neuroimmunol. 78, 143-151.
11. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011). Alzheimer's disease. Lancet 377, 1019-1031.
12. Ballatore, C., Brunden, K. R., Trojanowski, J. Q., Lee, V. M., Smith AB, I. I., and Huryn, D. M. (2011). Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies. Curr. Top. Med. Chem. 11, 317-330.
13. Bidmon, H. J., Görg, B., Palomero-Gallagher, N., Behne, F., Lahl, R., Pannek, H. W., Speckmann, E. J., and Zilles,K. (2004). Heat shock protein-27 is upregulated in the temporal cortex of patients with epilepsy. Epilepsia 45, 1549-1559.
14. Björkdahl, C., Sjögren, M. J., Zhou, X., Concha, H., Avila, J., Winblad, B., and Pei, J. J. (2008). Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. J. Neurosci. Res. 86, 1343-1352.
15. Burn, D. J. (2006). Cortical Lewy body disease and Parkinson's disease dementia. Curr. Opin. Neurol. 19, 572-579.
16. Ce, P., Erkizan, O., and Gedizlioglu, M. (2011). Elevated HSP27 levels during attacks in patients with multiple sclerosis. Acta Neurol. Scand. 124, 317-320.
17. Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., Heller, R., Oksenberg, J. R., and Steinman, L. (2001). The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731-1735.
18. Chang, W. H., Cemal, C. K., Hsu, Y. H., Kuo, C. L., Nukina, N., Chang, M. H., Hu, H. T., Li, C., and Hsieh, M. (2005). Dynamic expression of Hsp27 in the presence of mutant ataxin-3. Biochem. Biophys. Res. Commun. 336, 258-267.
19. Dabir, D. V., Trojanowski, J. Q., Richter-Landsberg, C., Lee, V. M., and Forman, M. S. (2004). Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. Am. J. Pathol. 164, 155-166.
20. Dearmond, S. J., and Prusiner, S. B. (2003). Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. Clin. Lab. Med. 23, 1-41.
21. Di Donato, S., Gellera, C., and Mariotti, C. (2001). The complex clinical and genetic classification of inherited ataxias. II. Autosomal recessive ataxias. Neurol. Sci. 22, 219-228.
22. Dubin, R. A., Wawrousek, E. F., and Piatigorsky, J. (1989). Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol. Cell. Biol. 9, 1083-1091.
23. Eidelberg, D., and Surmeier, D. J. (2011). Brain networks in Huntington disease. J. Clin. Invest. 121, 484-492.
24. Evgrafov, O. V., Mersiyanova, I., Irobi, J., Van Den Bosch, L., Dierick, I., Leung, C. L., Schagina, O., Verpoorten, N., Van Impe, K., Fedotov, V., Dadali, E., Auer-Grumbach, M., Windpassinger, C., Wagner, K., Mitrovic, Z., Hilton-Jones, D., Talbot, K., Martin, J. J., Vasserman, N., Tverskaya, S., Polyakov, A., Liem, R. K., Gettemans, J., Robberecht, W., De Jonghe, P., and Timmerman, V. (2004). Mutant small heatshock protein 27 causes axonal Charcot-Marie-tooth disease and distal hereditary motor neuropathy. Nat. Genet. 36, 602-606.
25. Fukushima, K., Mizuno, Y., Takatama, M., and Okamoto, K. (2006). Increased neuronal expression of alpha B-crystallin in human olivary hypertrophy. Neuropathology 26, 196-200.
26. Ganea, E. (2001). Chaperone-like activity of alpha-crystallin and other small heat shock proteins. Curr. Protein Pept. Sci. 2, 205-225.
27. Gangalum, R. K., Atanasov, I. C., Zhou, Z. H., and Bhat, S. P. (2011). AlphaBcrystallin is found in detergentresistant membrane microdomains and is secreted via exosomes from human retinal pigment epithelial cells. J. Biol. Chem. 286, 3261-3269.
28. Hagemann, T. L., Boelens, W. C., Wawrousek, E. F., and Messing, A. (2009). Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Hum. Mol. Genet. 18, 1190-1199.
29. Han, M. H., Hwang, S. I., Roy, D. B., Lundgren, D. H., Price, J. V., Ousman, S. S., Fernald, G. H., Gerlitz, B., Robinson, W. H., Baranzini, S. E., Grinnell, B. W., Raine, C. S., Sobel, R. A., Han, D. K., and Steinman, L. (2009). Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451, 1076-1081.
30. Hanihara, T., Amano, N., Takahashi, T., Itoh, Y., and Yagishita, S. (1998). Hypertrophy of the inferior olivary nucleus in patients with progressive supranuclear palsy. Eur. Neurol. 39, 97-102.
31. Head, M. W., Corbin, E., and Goldman, J. E. (1993). Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease. Am. J. Pathol. 143, 1743-1753.
32. Hollander, J. M., Martin, J. L., Belke, D. D., Scott, B. T., Swanson, E., Krishnamoorthy, V., and Dillmann, W. H. (2004). Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 110, 3544-3552.
33. Horwitz, J. (1992). Alpha-crystallin can function as a molecular chaperone. Proc. Natl. Acad. Sci. U.S.A. 89, 10449-10453.
34. Imura, T., Shimohama, S., Sato, M., Nishikawa, H., Madono, K., Akaike, A., and Kimura, J. (1999). Differential expression of small heat shock proteins in reactive astrocytes after focal ischemia: possible role of betaadrenergic receptor. J. Neurosci. 19, 9768-9779.
35. Ito, H., Okamoto, K., and Kato, K. (1997). Prostaglandins stimulate the stress-induced synthesis of hsp27 and alpha B crystallin. J. Cell. Physiol. 170, 255-262.
36. Iwaki, T., Iwaki, A., Tateishi, J., Sakaki, Y., and Goldman, J. E. (1993). Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am. J. Pathol. 143, 487-495.
37. Iwaki, T., Kume-Iwaki, A., Liem, R. K., and Goldman, J. E. (1989). Alpha B-crystallin is expressed in nonlenticular tissues and accumulates in Alexander's disease brain. Cell 57, 71-78.
38. Iwaki, T., Wisniewski, T., Iwaki, A., Corbin, E., Tomokane, N., Tateishi, J., and Goldman, J. E. (1992). Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions. Am. J. Pathol. 140, 345-356.
39. Jakob, U., Gaestel, M., Engel, K., and Buchner, J. (1993). Small heat shock proteins are molecular chaperones. J. Biol. Chem. 268, 1517-1520.
40. Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatr. 79, 368-376.
41. Jehle, S., Rajagopal, P., Bardiaux, B., Markovic, S., Kühne, R., Stout, J. R., Higman, V. A., Klevit, R. E., van Rossum, B. J., and Oschkinat, H. (2010). Solid-state NMR and SAXS studies provide a structural basis for the activation of alphaB-crystallin oligomers. Nat. Struct. Mol. Biol. 17, 1037-1042.
42. Jehle, S., van Rossum, B., Stout, J. R., Noguchi, S. M., Falber, K., Rehbein, K., Oschkinat, H., Klevit, R. E., and Rajagopal, P. (2009). alphaB-crystallin: a hybrid solid-state/solutionstate NMR investigation reveals structural aspects of the heterogeneous oligomer. J. Mol. Biol. 385, 1481-1497.
43. Jehle, S., Vollmar, B. S., Bardiaux, B., Dove, K. K., Rajagopal, P., Gonen, T., Oschkinat, H., and Klevit, R. E. (2011). N-terminal domain of alphaB-crystallin provides a conformational switch for multimerization and structural heterogeneity. Proc. Natl. Acad. Sci. U.S.A. 108, 6409-6414.
44. Kalwy, S. A., Akbar, M. T., Coffin, R. S., de Belleroche, J., and Latchman, D. S. (2003). Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainicacid-induced cell loss. Brain Res. Mol. Brain Res. 111, 91-103.
45. Kappé, G., Franck, E., Verschuure, P., Boelens, W. C., Leunissen, J. A., and de Jong, W. W. (2003). The human genome encodes 10 alpha-crystallinrelated small heat shock proteins: HspB1-10. Cell Stress Chaperones 8, 53-61.
46. Kato, S., Hirano, A., Umahara, T., Kato, M., Herz, F., and Ohama, E. (1992). Comparative immunohisto-chemical study on the expression of alpha B crystallin, ubiquitin and stress-response protein 27 in ballooned neurons in various disorders. Neuropathol. Appl. Neurobiol. 18, 335-340.
47. Kertesz, A. (2003). Pick complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurologist 9, 311-317.
48. Kirbach, B. B., and Golenhofen, N. (2011). Differential expression and induction of small heat shock proteins in rat brain and cultured hippocampal neurons. J. Neurosci. Res. 89, 162-175.
49. Komori, T. (1999). Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol. 9, 663-679.
50. Krishnan, J., Vannuvel, K., Andries, M., Waelkens, E., Robberecht, W., and Van Den Bosch, L. (2008). Over-expression of Hsp27 does not influence disease in the mutant SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. J. Neurochem. 106, 2170-2183.
51. Li, D. W., Liu, J. P., Mao, Y. W., Xiang, H., Wang, J., Ma, W. Y., Dong, Z., Pike, H. M., Brown, R. E., and Reed, J. C. (2005). Calciumactivated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation. Mol. Biol. Cell 16, 4437-4453.
52. Litt, M., Kramer, P., LaMorticella, D. M., Murphey, W., Lovrien, E. W., and Weleber, R. G. (1998). Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum. Mol. Genet. 7, 471-474.
53. Liu, S., Li, J., Tao,Y., and Xiao, X. (2007). Small heat shock protein alphaBcrystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. Biochem. Biophys. Res. Commun. 354, 109-114.
54. Lowe, J., Errington, D. R., Lennox, G., Pike, I., Spendlove, I., Landon, M., and Mayer, R. J. (1992). Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin. Neuropathol. Appl. Neurobiol. 18, 341-350.
55. Maatkamp, A., Vlug, A., Haasdijk, E., Troost, D., French, P. J., and Jaarsma, D. (2004). Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice. Eur. J. Neurosci. 20, 14-28.
56. Mao, J. J., Katayama, S., Watanabe, C., Harada, Y., Noda, K., Yamamura, Y., and Nakamura, S. (2001). The relationship between alphaBcrystallin and neurofibrillary tangles in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 27, 180-188.
57. Messing, A., Daniels, C. M., and Hagemann, T. L. (2010). Strategies for treatment in Alexander disease. Neurotherapeutics 7, 507-515.
58. Minami, M., Mizutani, T., Kawanishi, R., Suzuki, Y., and Mori, H. (2003). Neuronal expression of alphaB crystallin in cerebral infarction. Acta Neuropathol. 105, 549-554.
59. Morimoto, R. I., and Santoro, M. G. (1998). Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat. Biotechnol. 16, 833-838.
60. Nédellec, P., Edling, Y., Perret, E., Fardeau, M., and Vicart, P. (2002). Glucocorticoid treatment induces expression of small heat shock proteins in human satellite cell populations: consequences for a desminrelated myopathy involving the R120G alpha B-crystallin mutation. Neuromuscul. Disord. 12, 457-465.
61. Oba, M., Yano, S., Shuto, T., Suico, M. A., Eguma, A., and Kai, H. (2008). IFN-gamma down-regulates Hsp27 and enhances hyperthermiainduced tumor cell death in vitro and tumor suppression in vivo. Int. J. Oncol. 32, 1317-1324.
62. Ousman, S. S., Tomooka, B. H., van Noort, J. M., Wawrousek, E. F., O'Connor, K. C., Hafler, D. A., Sobel, R. A., Robinson, W. H., and Steinman, L. (2007). Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 448, 474-479.
63. Patel, Y. J., Payne Smith, M. D., de Belleroche, J., and Latchman, D. S. (2005). Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells. Brain Res. Mol. Brain Res. 134, 256-274.
64. Paulson, H. L., Bonini, N. M., and Roth, K. A. (2000). Polyglutamine disease and neuronal cell death. Proc. Natl. Acad. Sci. U.S.A. 97, 12957-12958.
65. Perry, J., Shin, D. S., Pratt, A. J., and Getzoff, E. D. (2010). Amyotrophic lateral sclerosis. Adv. Exp. Med. Biol. 685, 9-20.
66. Piao, C. S., Kim, S. W., Kim, J. B., and Lee, J. K. (2005). Coinduction of alphaB-crystallin and MAPKAPK-2 in astrocytes in the penumbra after transient focal cerebral ischemia. Exp. Brain Res. 163, 421-429.
67. Poulain, P., Gelly, J. C., and Flatters, D. (2010). Detection and architecture of small heat shock protein monomers. PLoS ONE 5, e9990. doi:10.1371/journal.pone.0009990
68. Prusiner, S. B. (1998). Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383.
69. Quraishe, S., Asuni, A., Boelens, W. C., O'Connor, V., and Wyttenbach, A. (2008). Expression of the small heat shock protein family in the mouse CNS: differential anatomical and biochemical compartmentalization. Neuroscience 153, 483-491.
70. Rejdak, K., Jackson, S., and Giovannoni, G. (2010). Multiple sclerosis: a practical overview for clinicians. Br. Med. Bull. 95, 79-104.
71. Renkawek, K., Bosman, G. J., and de Jong, W. W. (1994a). Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia. Acta Neuropathol. 87, 511-519.
72. Renkawek, K., Voorter, C. E., Bosman, G. J., van Workum, F. P., and de Jong, W. W. (1994b). Expression of alpha B-crystallin in Alzheimer's disease. Acta Neuropathol. 87, 155-160.
73. Renkawek, K., de Jong, W. W., Merck, K. B., Frenken, C. W., van Workum, F. P., and Bosman, G. J. (1992). alpha B-crystallin is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropathol. 83, 324-327.
74. Renkawek, K., Stege, G. J., and Bosman, G. J. (1999). Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease. Neuroreport 10, 2273-2276.
75. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H. X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., den Bergh R, V., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C.,Laing,N. G.,Soriano,E.,Pericak-Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., and Brown, R. H. Jr. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
76. Rothbard, J. B., Kurnellas, M. P., Brownell, S., Adams, C. M., Su, L., Axtell, R. C., Chen, R., Fathman, C. G., Robinson, W. H., and Steinman, L. (2012). Therapeutic effects of systemic administration of chaperone aB-crystallin associated with binding proinflammatory plasma proteins. J. Biol. Chem. 287, 9708-9721.
77. Schwarz, L., Vollmer, G., and Richter-Landsberg, C. (2010). The small heat shock protein HSP25/27 (HspB1) is abundant in cultured astrocytes and associated with astrocytic pathology in progressive supranuclear palsy and corticobasal degeneration. Int. J. Cell Biol. 2010, 717520.
78. Sharp, P., Krishnan, M., Pullar, O., Navarrete, R.,Wells, D., and de Belleroche, J. (2006). Heat shock protein 27 rescues motor neurons following nerve injury and preserves muscle function. Exp. Neurol. 198, 511-518.
79. Sharp, P. S., Akbar, M. T., Bouri, S., Senda, A., Joshi, K., Chen, H. J., Latchman, D. S., Wells, D. J., and de Belleroche, J. (2008). Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiol. Dis. 30, 42-55.
80. Shimura, H., Miura-Shimura, Y., and Kosik, K. S. (2004). Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival. J. Biol. Chem. 279, 17957-17962.
81. Shin,J. H.,Kim, S. W.,Lim,C. M., Jeong, J. Y., Piao, C. S., and Lee, J. K. (2009). alphaB-crystallin suppresses oxidative stress-induced astrocyte apoptosis by inhibiting caspase-3 activation. Neurosci. Res. 64, 355-361.
82. Shinohara, H., Inaguma, Y., Goto, S., Inagaki, T., and Kato, K. (1993). Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J. Neurol. Sci. 119, 203-208.
83. Simon, S., Fontaine, J. M., Martin, J. L., Sun, X., Hoppe, A. D., Welsh, M. J., Benndorf, R., and Vicart, P. (2007). Myopathy-associated alphaB-crystallin mutants: abnormal phosphorylation, intracellular location, and interactions with other small heat shock proteins. J. Biol. Chem. 282, 34276-34287.
84. Sinclair, C., Mirakhur, M., Kirk, J., Farrell, M., and Mcquaid, S. (2005). Upregulation of osteopontin and alpha beta-crystallin in the normalappearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays. Neuropathol. Appl. Neurobiol. 31, 292-303.
85. Steinman, L. (2008). New targets for treatment of multiple sclerosis. J. Neurol. Sci. 274, 1-4.
86. Sun, Y., and Macrae, T. H. (2005). The small heat shock proteins and theirrole in human disease. FEBS J. 272, 2613-2627.
87. Tolnay, M., and Probst, A. (2003). The neuropathological spectrum of neurodegenerative tauopathies. IUBMB Life 55, 299-305.
88. Tortosa, R., Vidal, E., Costa, C., Alamillo, E., Torres, J. M., Ferrer, I., and Pumarola, M. (2008). Stress response in the central nervous system of a transgenic mouse model of bovine spongiform encephalopathy. Vet. J. 178, 126-129.
89. Traub, R., Mitsumoto, H., and Rowland, L. P. (2011). Research advances in amyotrophic lateral sclerosis,2009 to 2010. Curr. Neurol. Neurosci. Rep. 11, 67-77.
90. Tsai, H. F., Lin, S. J., Li, C., and Hsieh, M. (2005). Decreased expression of Hsp27 and Hsp70 in transformed lymphoblastoid cells from patients with spinocerebellar ataxia type 7. Biochem. Biophys. Res. Commun. 334, 1279-1286.
91. van der Weerd, L., Tariq Akbar, M., Aron Badin, R., Valentim, L. M., Thomas, D. L., Wells, D. J., Latchman, D. S., Gadian, D. G., Lythgoe, M. F., and de Belleroche, J. S. (2010). Overexpression of heat shock protein 27 reduces cortical damage after cerebral ischemia. J. Cereb. Blood Flow Metab. 30, 849-856.
92. Van Montfort, R., Slingsby, C., and Vierling, E. (2001). Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv. Protein Chem. 59, 105-156.
93. van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., el Ouagmiri, M., Polman, C. H., Lassmann, H., and Ravid, R. (1995). The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375, 798-801.
94. Verbeek, R., van Dongen, H., Wawrousek, E. F., Amor, S., and van Noort, J. M. (2007). Induction of EAE by T cells specific for alpha B-crystallin depends on prior viral infection in the CNS. Int. Immunol. 19, 277-285.
95. Vezzani, A., French, J., Bartfai, T., and Baram, T. Z. (2011). The role of inflammation in epilepsy. Nat. Rev. Neurol. 7, 31-40.
96. Vicart,P.,Caron,A.,Guicheney,P.,Li,Z., Prévost, M. C., Faure, A., Chateau, D., Chapon, F., Tomé, F., Dupret, J. M., Paulin, D., and Fardeau, M. (1998). A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 20, 92-95.
97. Vidal, E., Acín, C., Foradada, L., Monzón, M., Márquez, M., Monleón, E., Pumarola, M., Badiola, J. J., and Bolea, R. (2009). Immunohistochemical characterisation of classical scrapie neuropathology in sheep. J. Comp. Pathol. 141, 135-146.
98. Vleminckx, V., Van Damme, P., Goffin, K., Delye, H., Van Den Bosch, L., and Robberecht, W. (2002). Upregulation of HSP27 in a transgenic model of ALS. J. Neuropathol. Exp. Neurol. 61, 968-974.
99. Wang, J., Martin, E., Gonzales, V., Borchelt, D. R., and Lee, M. K. (2008). Differential regulation of small heat shock proteins in transgenic mouse models of neurodegenerative diseases. Neurobiol. Aging 29, 586-597.
100. Weder, N. D., Aziz, R., Wilkins, K., and Tampi, R. R. (2007). Frontotemporal dementias: a review. Ann. Gen. Psychiatry 6, 15.
101. Wen, F. C., Li, Y. H., Tsai, H. F., Lin, C. H., Li, C., Liu, C. S., Lii, C. K., Nukina, N., and Hsieh, M. (2003). Down-regulation of heat shock protein 27 in neuronal cells and non-neuronal cells expressing mutant ataxin-3. FEBS Lett. 546, 307-314.
102. Wilhelmus, M. M., Boelens, W. C., Otte-Höller, I., Kamps, B., Kusters, B., Maat-Schieman, M. L., de Waal, R. M., and Verbeek, M. M. (2006a). Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity. Acta Neuropathol. 111, 139-149.
103. Wilhelmus, M. M., Otte-Höller, I., Wesseling, P., de Waal, R. M., Boelens, W. C., and Verbeek, M. M. (2006b). Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol. Appl. Neurobiol. 32, 119-130.
104. Wyttenbach, A., Sauvageot, O., Carmichael, J., Diaz-Latoud, C., Arrigo, A. P., and Rubinsztein, D. C. (2002). Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11, 1137-1151.
105. Zabel, C., Chamrad, D. C., Priller, J., Woodman, B., Meyer, H. E., Bates, G. P., and Klose, J. (2002). Alterations in the mouse and human proteosome caused by Huntington's disease. Mol. Cell Proteomics 1, 366-375.
106. Zhang, Y., Huang, L., Zhang, J., Moskophidis, D., and Mivechi, N. F. (2002). Targeted disruption of hsf1 leads to lack of thermotolerance and defines tissue-specific regulation for stress-inducible Hsp molecular chaperones. J. Cell. Biochem. 86, 376-393.
107. Zourlidou, A., Gidalevitz, T., Kristiansen, M., Landles, C., Woodman, B., Wells, D. J., Latchman, D. S., de Belleroche, J., Tabrizi, S. J., Morimoto, R. I., and Bates, G. P. (2007). Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. Hum. Mol. Genet. 16, 1078-1090.
108. Zourlidou, A., Payne Smith, M. D., and Latchman, D. S. (2004). HSP27 but not HSP70 has a potent protective effect against alpha-synucleininduced cell death in mammalian neuronal cells. J. Neurochem. 88, 1439-1448.